A detailed history of Virtus ETF Advisers LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 4,642 shares of TYRA stock, worth $70,651. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,642
Previous 4,560 1.8%
Holding current value
$70,651
Previous $72,000 51.39%
% of portfolio
0.05%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$16.7 - $24.36 $1,369 - $1,997
82 Added 1.8%
4,642 $109,000
Q2 2024

Aug 14, 2024

BUY
$14.45 - $20.22 $65,892 - $92,203
4,560 New
4,560 $72,000

Others Institutions Holding TYRA

About Tyra Biosciences, Inc.


  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $639M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.